Femasys CEO buys shares and receives new warrants
Femasys Inc. CEO Kathy Lee-Sepsick reported acquiring company securities on August 7, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Femasys Inc. CEO Kathy Lee-Sepsick reported acquiring company securities on August 7, 2026. She purchased 15,625 shares of Common Stock at $3.20 per share, for an aggregate $50,000, under a Securities Purchase Agreement with Femasys and other purchasers. She also received a warrant for 15,625 shares exercisable at $2.95 per share from August 10, 2026 until August 10, 2029, and a separate Milestone warrant for 15,625 shares at the same exercise price, which becomes exercisable only after specified revenue and stock-price conditions are met and is subject to Nasdaq-related exercise limitations.
Insider Trade Summary
Net Buyer: 15,625 shares
Net Buy
3 txns
Insider
Lee-Sepsick Kathy
Role
Chief Executive Officer
Bought
15,625 shs ($50K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock Purchase Warrant F2, F4, F3 | 15,625 | -- | -- |
| Grant/Award | Common Stock Purchase Warrant (Milestone) F2, F4, F5, F3 | 15,625 | -- | -- |
| Purchase | Common Stock F1 | 15,625 | $3.20 | $50K |
Holdings After Transaction:
Common Stock Purchase Warrant — 15,625 contracts (Direct);
Common Stock Purchase Warrant (Milestone) — 15,625 contracts (Direct);
Common Stock — 15,625 shares (Direct)
Footnotes (5)
- F1. The purchase price paid by the reporting person for the Shares was $3.20 per share pursuant to the Securities Purchase Agreement, dated as of August 7, 2026, by and among Femasys Inc. and the purchasers party thereto.
- F2. Holder may, at its option, exercise the Common Warrant, subject to the terms and conditions thereof, at an exercise price of $2.95 per share of Common Stock. The exercise price is subject to adjustment in accordance with the terms of the Common Warrant and will be subject to standard adjustments in the event of any stock split, stock dividend, stock combination, recapitalization or other similar transactions.
- F3. The Holder's ability to exercise the subject Warrant for shares of Common Stock is subject to certain limitations, in accordance with rules of the Nasdaq Capital Market.
- F4. The reported securities were purchased by the reporting person for an aggregate amount of $50,000.
- F5. The Common Warrant (Milestone) is exercisable only from and after the Milestone Date, being the first date on or after August 10, 2027 on which both (i) the Company has achieved U.S. revenue of $1,500,000 for any fiscal quarter, as reported in a Form 10-Q or Form 10-K, and (ii) the volume-weighted average price of the Common Stock has satisfied certain price conditions specified in the warrant. The warrant expires on the earlier of (i) three years after the effective date of a registration statement registering the resale of the Warrant Shares and (ii) 45 days after the Company delivers notice that the Milestone Date has occurred. As of the date of this report, neither the Milestone Date nor the expiration date is determinable.
Key Figures
Common shares purchased: 15,625 shares
Purchase price per share: $3.20 per share
Aggregate purchase amount: $50,000
+4 more
7 metrics
Common shares purchased
15,625 shares
Common Stock purchased on August 7, 2026
Purchase price per share
$3.20 per share
Price paid for Common Stock under Securities Purchase Agreement
Aggregate purchase amount
$50,000
Total paid for reported securities by the reporting person
Warrant exercise price
$2.95 per share
Exercise price for both Common Stock Purchase Warrants
Standard warrant shares
15,625 shares
Underlying shares for Common Stock Purchase Warrant exercisable from August 10, 2026
Milestone warrant shares
15,625 shares
Underlying shares for Common Stock Purchase Warrant (Milestone)
Revenue milestone
$1,500,000
U.S. revenue in any fiscal quarter required for Milestone Date
Key Terms
Common Stock Purchase Warrant, Milestone Date, volume-weighted average price, registration statement, +1 more
5 terms
Common Stock Purchase Warrant financial
"Holder may, at its option, exercise the Common Warrant"
A common stock purchase warrant is a tradable certificate that gives its holder the right to buy a company’s common shares at a fixed price for a set period. Think of it as a coupon that lets you buy stock later at today’s agreed price; it can amplify gains if the share price rises but also can increase the total number of shares outstanding, which may reduce existing owners’ percentage of the company. Investors watch warrants because they offer leveraged upside and can affect future share value and ownership.
Milestone Date financial
"exercisable only from and after the Milestone Date, being the first date"
volume-weighted average price financial
"the volume-weighted average price of the Common Stock has satisfied certain price"
Volume-weighted average price (VWAP) is the average price of a stock over a specific time period where each trade is weighted by the number of shares traded, so larger trades influence the average more than small ones. Investors and traders use VWAP as a reference point to judge whether trades are happening at relatively good or poor prices—like checking the average price paid for an item at a market where bulk purchases count more than single-item buys.
registration statement regulatory
"three years after the effective date of a registration statement registering the resale"
A registration statement is a formal document that companies file with a government agency to offer new shares of stock to the public. It provides essential information about the company's finances, operations, and risks, helping investors make informed decisions. Think of it as a detailed product description that ensures transparency and trust before buying into a company.
Nasdaq Capital Market financial
"subject to certain limitations, in accordance with rules of the Nasdaq Capital Market"
The Nasdaq Capital Market is a platform where smaller, emerging companies can list their shares for trading by investors. It provides these companies with access to funding and visibility, helping them grow, much like a local marketplace where new vendors can introduce their products to potential customers. For investors, it offers opportunities to discover early-stage companies with growth potential.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did FEMY CEO Kathy Lee-Sepsick buy in this Form 4 filing?
Kathy Lee-Sepsick purchased 15,625 shares of Femasys Inc. Common Stock at $3.20 per share. The purchase, totaling $50,000, was made under a Securities Purchase Agreement dated August 7, 2026 with Femasys and other purchasers.
What warrants did the FEMY CEO receive according to this Form 4?
Kathy Lee-Sepsick received two Common Stock Purchase Warrants, each covering 15,625 shares at an exercise price of $2.95 per share. One warrant is exercisable from August 10, 2026, and the other is a Milestone warrant with additional conditions.
How large was the total investment reported by the FEMY CEO?
The reported securities were purchased for an aggregate amount of $50,000. This total corresponds to the acquisition of 15,625 Common Shares at $3.20 per share, as described in the Securities Purchase Agreement footnote.
What are the terms of the standard warrant reported for FEMY?
The standard Common Warrant allows the holder to acquire 15,625 shares at an exercise price of $2.95 per share from August 10, 2026 until August 10, 2029, with price adjustments for stock splits and similar corporate actions.
When does the FEMY Milestone warrant become exercisable?
The Milestone warrant becomes exercisable on the first date on or after August 10, 2027 when Femasys reports U.S. revenue of $1,500,000 for any fiscal quarter and specified volume-weighted average price conditions are met.
Are there limits on exercising the FEMY warrants reported here?
Yes. The footnotes state the holder’s ability to exercise the warrants is subject to limitations in accordance with Nasdaq Capital Market rules, and the Milestone warrant’s timing also depends on achieving revenue and price conditions.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates